# Comparison of Two Dosages of Heparin Before Extracorporeal Circulation

> **NCT03752437** · PHASE4 · COMPLETED · sponsor: **Astes** · enrollment: 150 (actual)

## Conditions studied

- Extracorporeal Circulation; Complications

## Interventions

- **DIAGNOSTIC_TEST:** ACT (Activated Clotting Time)
- **DRUG:** Heparin

## Key facts

- **NCT ID:** NCT03752437
- **Lead sponsor:** Astes
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-01
- **Primary completion:** 2021-09-30
- **Final completion:** 2021-09-30
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2022-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03752437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03752437, "Comparison of Two Dosages of Heparin Before Extracorporeal Circulation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03752437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*